Fate Therapeutics Inc

Fate Therapeutics is a clinical-stage biopharmaceutical company. The company's immuno-oncology product candidates include: FATE-NK100, which is a natural killer (NK) cell cancer immunotherapy comprised of adaptive memory NK cells; and FT500, which is an off-the-shelf NK cell cancer immunotherapy for the treatment of solid tumors; and FT516, which is an off-the-shelf immunotherapy for the treatment of cancer. The company's immuno-regulation product candidates include: ProTmune?, which is an investigational programmed cellular immunotherapy for use as an allogeneic hematopoietic cell transplantation cell graft; and FT301, which is an off-the-shelf, immuno-regulatory cell product candidate.
  • TickerFATE
  • ISINUS31189P1021
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology
  • CountryUnited States
Wedbush Research

Wedbush Morning Call - May 26 2020 6:20AM

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

ValuEngine Rating and Forecast Report for FATE

ValuEngine Rating and Forecast Report for FATE

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Matthew Barcus
  • Robert Driscoll

AACR II 2020 Abstract Roundup for Covered Companies

Wedbush Research

Wedbush Morning Call - May 26 2020 6:20AM

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Matthew Barcus
  • Robert Driscoll

AACR II 2020 Abstract Roundup for Covered Companies

Wedbush Research

Wedbush Morning Call - May 18 2020 6:54AM

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Kambiz Yazdi
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

ValuEngine Rating and Forecast Report for FATE

ValuEngine Rating and Forecast Report for FATE

ValuEngine Rating and Forecast Report for FATE

ValuEngine Rating and Forecast Report for FATE

ValuEngine Rating and Forecast Report for FATE

ValuEngine Rating and Forecast Report for FATE

ValuEngine Rating and Forecast Report for FATE

ValuEngine Rating and Forecast Report for FATE

ValuEngine Rating and Forecast Report for FATE

ValuEngine Rating and Forecast Report for FATE

ResearchPool Subscriptions

Get the most out of your insights

Get in touch